Ardent Health Inc. logo

Ardent Health Inc.

ARDT | NYSE
Chart Builder DCF Calculator
$10.61
+$0.13 (+1.24%)
At close: Sep 21, 2026, 4:00 PM ET
$10.80
+$0.19 (+1.79%)
Pre-market: Sep 22, 2026, 9:16 AM ET

Market Data

Market Cap
$1.52B
Enterprise Value
$3.06B
Beta
0.71
Average Volume
508.12K
Shares Outstanding (Diluted)
143.05M
Shares Change YoY
1.38%
Institutional Ownership
75.67%
Exchange
NYSE
ISIN
US03980N1072

Price Performance

Price Change 1M
-4.9%
Price Change 3M
15.6%
Price Change 6M
20.8%
Price Change YTD
22.8%
Price Change 1Y
-18.6%
Price Change 3Y
-38.7%
Price Change 5Y
-38.7%
1M CAGR (ann.)
-8.1%
1Y CAGR (ann.)
-20.3%
5Y CAGR (ann.)
N/A
All-Time CAGR
-17.3%

Valuation

PE Ratio
19.29
Forward PE
8.60
PEG Ratio
-0.27
Forward PEG
0.88
PS Ratio
0.24
Forward PS
0.20
PB Ratio
1.13
P/FCF Ratio
7.17
P/Adj. FCF Ratio
8.58
P/OCF Ratio
2.95
EV/Sales
0.48
EV/EBIT
12.91
EV/EBITDA
7.62
EV/FCF
14.43
Earnings Yield
5.2%
FCF Yield
14.0%
Adj. FCF Yield
11.7%

Financial Health

Net Debt
$377.31M
Total Debt
$2.27B
Cash & Short-Term Investments
$724.48M
Total Assets
$5.28B
Current Ratio
2.10
Quick Ratio
1.99
Debt / Equity Ratio
1.68
Debt / EBITDA
5.64
Debt / FCF
10.68
OCF / Debt
0.20
Interest Coverage
9.74
Altman Z-Score
2.01
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
30.0%
Operating Profit Margin
7.5%
EBITDA Margin
6.3%
Net Profit Margin
1.2%
FCF Margin
3.3%
Adj. FCF Margin
2.8%
SBC / Revenue
0.4%
SBC Impact (per share)
-16.4%

Returns

Return on Assets
1.5%
Return on Equity
5.2%
Return on Invested Capital
9.3%
Return on Capital Employed
11.2%
Return on Tangible Assets
1.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
33.6%
Revenue CAGR 5Y
36.1%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
28.4%
EPS CAGR 5Y
84.3%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
171.6%
FCF CAGR 5Y
68.5%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
12
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
$0.24
EPS Growth Est (next Q)
-53.9%
Revenue Est (next Q)
$1.6B
Revenue Growth Est (next Q)
1.7%

Fair Value Estimates

Graham Number
$12.33
Graham Upside
16.2%
Lynch Fair Value
$13.75
Lynch Upside
29.6%
Price Target
$13.50
Price Target Upside
27.2%

Cash Flow

Operating Cash Flow
$449.91M
Free Cash Flow
$212.26M
Adj. Free Cash Flow
$177.34M
FCF Per Share
$2.12
OCF Per Share
$3.60
OCF/S Ratio
8.0%

Income Statement

Revenue
$6.41B
Gross Profit
$1.92B
Operating Income
$483.2M
EBITDA
$401.7M
Net Income
$78.23M
EPS (Diluted)
$0.55
Revenue / Employee
$286.62K
Profit / Employee
$3.5K
Employees
22,350

© 2026 bestshares.com. All rights reserved.